Education
About Us
Working with TipRanks
Follow Us
Medexus Pharmaceuticals Inc (TSE:MDP)
TSX:MDP
Earnings Data
Report Date
Nov 05, 2025Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.02Last Year’s EPS
0Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted the successful launch and positive early performance of GRAFAPEX, along with strategic achievements such as NTAP reimbursement approval and improved gross margins. However, these were balanced by challenges including declining revenues and adjusted EBITDA, increased expenses, and concerns about tariffs affecting costs. The overall sentiment is cautious optimism, with focus on future growth driven by GRAFAPEX.Company Guidance
Successful Launch of GRAFAPEX
GRAFAPEX generated $3 million in product-level net revenue in fiscal Q1 '26, with early adoption by major commercial payers and healthcare institutions. 36 of 180 transplant centers, representing 24% of total allo-HSCT procedures in the U.S., have ordered GRAFAPEX.
Positive NTAP Reimbursement for GRAFAPEX
Secured approval for NTAP reimbursement for GRAFAPEX from Medicare, providing up to $21,411 of additional reimbursement per eligible patient starting October 1, 2025.
Trecondyv Growth in Canada
Unit demand for Trecondyv grew 38% over the trailing 12-month period, with BC, Manitoba, Ontario, and Quebec executing listing agreements for reimbursement.
Gross Margin Improvement
Gross margin improved to 56.0% in fiscal Q1 '26 from 54.4% in the same period last year.
Debt Reduction
Net debt decreased to $12.6 million as of June 30, 2025, compared to $13.2 million as of March 31, 2025.
TSE:MDP Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TSE:MDP Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 12, 2025 | C$2.75 | C$2.67 | -2.91% |
Jun 25, 2025 | C$3.35 | C$3.15 | -5.97% |
Feb 05, 2025 | C$3.79 | C$3.05 | -19.53% |
Nov 07, 2024 | C$2.20 | C$2.17 | -1.36% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Medexus Pharmaceuticals Inc (TSE:MDP) report earnings?
Medexus Pharmaceuticals Inc (TSE:MDP) is schdueled to report earning on Nov 05, 2025, Before Open (Confirmed).
What is Medexus Pharmaceuticals Inc (TSE:MDP) earnings time?
Medexus Pharmaceuticals Inc (TSE:MDP) earnings time is at Nov 05, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:MDP EPS forecast?
TSE:MDP EPS forecast for the fiscal quarter 2026 (Q2) is -0.02.